FY24 Total Revenue achieved of 10% to IDR 3,919 bn. There was robust top-line growth across all revenue segments Herbal and Supplements with 6% YoY; Food and Beverages (18% YoY); and Pharmaceutical (10% YoY). Operating Profit increased 19% YoY to IDR 1,473 bn with a General and Administrative Expenses declining 2% YoY to IDR 201 bn. But OPEX inclined due to selling expense increasing 10% YoY to IDR 626 bn. Although OPEX inclined, SIDO still improved its OPM with 37% (vs. 34% in FY2023). Bottom-line in FY24 shot up with NPAT growing 23% YoY; NPM has also shown an improvement to 29% (vs. 26% in FY23).
Download full report HERE.
